Please assess the completion status of the following clinical trial:

Trial Title: A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is a male or female subject 40 years of age or older~Exclusion Criteria:~* Females who are pregnant, lactating, breast-feeding or planning to become pregnant during the study

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TD-4208-1 (Type: EXPERIMENTAL): 88 mcg
- TD-4208-2 (Type: EXPERIMENTAL): 175 mcg
- Tiotropium (Type: ACTIVE_COMPARATOR): 18 mcg

Based on this trial design, predict the completion outcome and termination type (if applicable).